NCT02976701 - Effect of DLBS1033 After Primary PCI in Patients With STE-ACS | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

January 31, 2023

Study Completion Date

March 31, 2023

Conditions

ST Elevation Myocardial Infarction

Interventions

DRUG

DLBS1033

DRUG

Placebo

DRUG

Standard therapy

Standard therapy which consists of: aspirin enteric-coated tablet 1 x 80 mg and clopidogrel film-coated tablet 1 x 75 mg daily for four weeks will be given to both arms.

Trial Locations (1)

13570

Binawaluya Cardiac Hospital, Jakarta